<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03273036</url>
  </required_header>
  <id_info>
    <org_study_id>ID 03-54-23</org_study_id>
    <nct_id>NCT03273036</nct_id>
  </id_info>
  <brief_title>Perioperative Outcome of Corticosteroids in Transforaminal Endoscopic Lumbar Discectomy</brief_title>
  <official_title>Comparison of Perioperative Outcome Between Corticosteroids and Placebo in Transforaminal Endoscopic Lumbar Discectomy. A Single-center Randomized Placebo-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramathibodi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ramathibodi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The endoscopic discectomy has rapidly developed and increased need by patients. This
      procedure is widely performed by interventional pain physicians as well as by spine surgeons
      because it requires no general anesthesia or admission to a hospital. Many studies were
      reported that corticosteroid injection can inhibit persistent postoperative pain in lumbar
      discectomy. However, data of perioperative epidural steroids after an endoscopic discectomy
      is lacking.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To examine whether corticosteroid administered epidural space in patients undergoing
      endoscopic lumbar discectomy reduces postoperative morphine consumption, back and leg pain
      relief, improves functional disability comparing to placebo
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2014</start_date>
  <completion_date type="Actual">May 1, 2015</completion_date>
  <primary_completion_date type="Actual">May 1, 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative morphine consumption</measure>
    <time_frame>Post operative 24 hour of morphine consumption in mg</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analog score (back and leg) 0-10</measure>
    <time_frame>1 day, 2, 6 ,12, 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry disability index (ODI</measure>
    <time_frame>2, 6 ,12, 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MacNab scores</measure>
    <time_frame>2, 6 ,12, 24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Lumbar Disc Herniation</condition>
  <arm_group>
    <arm_group_label>epidural steroid injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40 mg triamcinolone acetate 1 cc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no injection agent</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>40 mg Triamcinolone acetate 1 cc</intervention_name>
    <description>40 mg Triamcinolone acetate 1 cc</description>
    <arm_group_label>epidural steroid injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>no injected agent</description>
    <arm_group_label>placebo injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lumbar disc herniation patient age 20-45 year-old who have symptom duration was at
             least 6 weeks and conservative treatment failed

        Exclusion Criteria:

          -  Refuse to participate and inform consent, Previous spinal surgery, History of allergic
             to steroid
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2017</study_first_submitted>
  <study_first_submitted_qc>September 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 6, 2017</study_first_posted>
  <last_update_submitted>September 1, 2017</last_update_submitted>
  <last_update_submitted_qc>September 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ramathibodi Hospital</investigator_affiliation>
    <investigator_full_name>Jatupon Kongtharvonskul</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

